We are live on
!
Find out more
10x Genomics
TXG
TXG
329 hedge funds and large institutions have $2.66B invested in 10x Genomics in 2026 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 115 increasing their positions, 102 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,364% more call options, than puts
Call options by funds: $23.6M | Put options by funds: $1.61M
133% more funds holding in top 10
Funds holding in top 10: 3 → 7 (+4)
33% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 42
32% more capital invested
Capital invested by funds: $2.02B → $2.66B (+$640M)
13% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 102
2% more funds holding
Funds holding: 322 → 329 (+7)
0.26% more ownership
Funds ownership: 106.12% → 106.38% (+0.26%)
Holders
329
Holders Change
+7
Holders Change %
+2.17%
% of All Funds
4.05%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.09%
New
56
Increased
115
Reduced
102
Closed
42
Calls
$23.6M
Puts
$1.61M
Net Calls
+$21.9M
Net Calls Change
+$18.8M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$116M |
| 2 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
+$21.8M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$19.8M |
| 4 |
Goldman Sachs
New York
|
+$17.7M |
| 5 |
CC
Casdin Capital
New York
|
+$17.5M |
